Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease

被引:2
|
作者
Zhang, Hong-Da [1 ]
Yan, Yi [2 ,3 ]
He, Yang-Yang [4 ]
Liu, Qian-Qian [1 ]
Peng, Fu-Hua [1 ]
Yan, Xin-Xin [1 ]
Han, Zhi-Yan [1 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Shanghai Jiao Tong Univ, Heart Ctr, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Congenital Heart Dis, Sch Med, Shanghai 200127, Peoples R China
[4] Henan Univ, Sch Pharm, Kaifeng 475004, Peoples R China
[5] Fuwai Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Dept Anesthesiol,State Key, 167 Beilishi Rd, Beijing 100037, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Pulmonary arterial hypertension; Congenital heart disease; Exercise intolerance; Cardiopulmonary exercise testing; Peak oxygen uptake; EISENMENGER SYNDROME; ADULTS; SURVIVAL; ERA;
D O I
10.1016/j.ijcard.2022.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise intolerance is a major manifestation of pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). We aimed to investigate the characteristics of exercise intolerance in different subgroups of PAH-CHD. Methods: We retrospectively enrolled 171 adult patients with PAH-CHD and 30 age and sex-matched healthy subjects and performed cardiopulmonary exercise testing. Gas exchange parameters, including peak oxygen uptake (peak VO2), anaerobic threshold, and the slope of ventilatory equivalent for carbon dioxide (VE/VCO2 slope), were recorded. Results: The median age of patients at enrollment was 27.8 years, and 131 (76.6%) were female. Peak VO2 was reduced in patients compared to healthy controls (median, 14.8 ml/kg/min versus 26.9 ml/kg/min, p < 0.001). Of all 171 patients, 60 (35.1%) had Eisenmenger syndrome, 35 (20.5%) had PAH associated with systemic-to-pulmonary shunts (PAH-SP), 39 (22.8%) had PAH with small defects (PAH-SD), and 37 (21.6%) had PAH after cardiac defect correction (PAH-CD). Patients with Eisenmenger syndrome had the lowest peak VO2 (p = 0.003) and the highest VE/VCO2 slope (p = 0.012), compared with other patients, representing the worst exercise capacity and ventilatory efficiency. Patients with PAH-SP had the best exercise capacity among the four groups, indicated by the highest peak VO2 (p = 0.003) compared with other patients. Peak VO2 was negatively correlated with pulmonary vascular resistance (r =-0.411, p < 0.001). Conclusions: Exercise capacity was severely reduced in patients with PAH-CHD. Among the four subgroups, patients with Eisenmenger syndrome had the worst exercise capacity and ventilatory efficiency.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [21] Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
    Baroutidou, Amalia
    Arvanitaki, Alexandra
    Hatzidakis, Adam
    Pitsiou, Georgia
    Ziakas, Antonios
    Karvounis, Haralambos
    Giannakoulas, George
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [22] Pulmonary arterial hypertension in adults with congenital heart disease
    Bouzas, B
    Gatzoulis, MA
    REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (05): : 465 - 469
  • [23] Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease
    Fournier, Emmanuelle
    Selegny, Maelle
    Amsallem, Myriam
    Haddad, Francois
    Cohen, Sarah
    Valdeolmillos, Estibaliz
    Le Pavec, Jerome
    Humbert, Marc
    Isorni, Marc -Antoine
    Azarine, Arshid
    Sitbon, Olivier
    Jais, Xavier
    Savale, Laurent
    Montani, David
    Fadel, Elie
    Zoghbi, Joy
    Belli, Emre
    Hascoet, Sebastien
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (05): : 333 - 343
  • [24] Exercise physiology in pulmonary hypertension patients with and without congenital heart disease
    Righini, Francesca M.
    Apostolo, Anna
    Heck, Pinar B.
    Farina, Stefania
    Hager, Alfred
    Correale, Michele
    Badagliacca, Roberto
    Barbieri, Simone
    Sciomer, Susanna
    Agostoni, Piergiuseppe
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (01) : 86 - 93
  • [25] A review of the management of pulmonary arterial hypertension associated with congenital heart disease
    Harries, Carl
    Armstrong, Iain
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2012, 11 (02) : 239 - 247
  • [26] Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification
    Ramjug, Sheila
    Hussain, Nehal
    Hurdman, Judith
    Billings, Catherine
    Charalampopoulos, Athanasios
    Elliot, Charlie A.
    Sabroe, Ian
    Kiely, David G.
    Condliffe, Robin
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (05) : 610 - 618
  • [27] Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry
    Rose, M. L.
    Strange, G.
    King, I.
    Arnup, S.
    Vidmar, S.
    O'Donnell, C.
    Kermeen, F.
    Grigg, L.
    Weintraub, R. G.
    Celermajer, D. S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (08) : 874 - 879
  • [28] Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
    Ma, Runwei
    Cheng, Liming
    Song, Yi
    Sun, Yi
    Gui, Wenting
    Deng, Yao
    Xie, Chao
    Liu, Min
    FRONTIERS IN MEDICINE, 2022, 9
  • [29] Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Mahmoud, Ahmed K.
    Abbas, Mohammed Tiseer
    Kamel, Moaz A.
    Farina, Juan M.
    Pereyra, Milagros
    Scalia, Isabel G.
    Barry, Timothy
    Chao, Chieh-Ju
    Marcotte, Francois
    Ayoub, Chadi
    Scott, Robert L.
    Majdalany, David S.
    Arsanjani, Reza
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [30] Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Awad, Abdulhalim
    Elnemr, Shimaa
    Hodeib, Hossam
    El Amrousy, Doaa
    PEDIATRIC CARDIOLOGY, 2022, 43 (06) : 1264 - 1270